Genomes and Genes
measles mumps rubella vaccine
Summary: A combined vaccine used to prevent MEASLES; MUMPS; and RUBELLA.
Publications223 found, 100 shown here
- Taking a closer look: an examination of measles, mumps, and rubella immunization uptake in SaskatoonKyla Avis
College of Nursing, University of Saskatchewan, Saskatoon, SK
Can J Public Health 98:417-21. 2007....
- MMR vaccine uptake rates: a data validation studyS Ghebrehewet
Communicable Disease Unit, Countess of Chester Health Park, Cheshire and Merseyside Health Protection Team, Public Health Laboratory, Liverpool Road, Chester CH2 1UL
Commun Dis Public Health 6:144-6. 2003..Electronic transfer of information from practices to the CHCS and between CHCSs, i.e. across boundaries, could improve data accuracy...
- [Using surveys of schoolchildren to evaluate coverage with and opportunity for vaccination in Costa Rica]Nidia Calvo
Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud INCIENSA, Tres Rios, Costa Rica
Rev Panam Salud Publica 16:118-24. 2004....
- Safety concerns regarding combination vaccines: the experience in JapanMargie C Andreae
CHEAR Child Health Evaluation and Research Unit, University of Michigan, Ann Arbor, MI 48109 0456, USA
Vaccine 22:3911-6. 2004....
- Susceptibility of medical students to vaccine-preventable viral diseases: a serological studyJunko Kukino
Department of General Medicine, Juntendo University School of Medicine, 2 1 1 Bunkyo ku, Tokyo 113 8421, Japan
J Infect Chemother 10:335-7. 2004..A weak correlation was observed among antibody titers for measles, rubella, and mumps but not for varicella. These results suggest that MMR vaccine might be effective in people with low levels of antibody to measles, rubella, and mumps...
- The seroepidemiology of measles in Western EuropeH de Melker
National Institute of Public Health and the Environment, Bilthoven, The Netherlands
Epidemiol Infect 126:249-59. 2001..In the high susceptibility country the priority will be to increase infant vaccine coverage and reduce regional variation in coverage levels...
- Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillanceR G Pebody
Sero Epidemiology Unit, Immunisation Division, PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London, UK
Vaccine 20:1134-40. 2002..Further studies including qualitative measures, such as avidity, in different populations are merited and may contribute to the understanding of MMR population protection...
- Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-upA Patja
Hospital for Children and Adolescents, Helsinki University Central Hospital, Finland
Pediatr Infect Dis J 19:1127-34. 2000..Several disorders have been attributed to measles-mumps-rubella (MMR) vaccination during the past decade. The aim of this prospective follow-up study was to identify serious adverse events causally related to MMR vaccination...
- Accuracy of routine data on MMR vaccination coverage and validity of parental recall of vaccinationG Lyratzopoulos
Commun Dis Public Health 5:305-10. 2002..Routine data may modestly underestimate vaccination coverage and significantly overestimate measles susceptibility. Many parents of MMR unvaccinated children believe that their children have been vaccinated...
- Parents' perspectives on the MMR immunisation: a focus group studyM Evans
Division of Primary Health Care, University of Bristol
Br J Gen Pract 51:904-10. 2001..We need to understand what influences parents' decisions on whether to accept MMR or not so that health professionals can provide a service responsive to their needs...
- The effectiveness of the mumps component of the MMR vaccine: a case control studyRichard Harling
HPA CDSC, 61 Colindale Avenue, London NW9 5EQ, UK
Vaccine 23:4070-4. 2005..Two doses of vaccine were more effective (88% (95% CI: 62-96%)) than a single dose (64% (95% CI: 40-78%)). The current two-dose vaccination programme remains the best method for controlling mumps infection in the community...
- A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, AustraliaHeath Kelly
Victorian Infectious Diseases Reference Laboratory, Locked Bag 815, 10 Wreckyn Street, North Melbourne 3051, Carlton South, VIC 3053, Australia
Vaccine 20:3130-6. 2002....
- Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionalsM Petrovic
Department of Public Health, North Wales Health Authority, Preswylfa, Mold, Flintshire CH7 1PZ, UK
BMJ 322:82-85. 2001..To determine the knowledge, attitudes, and practices among health professionals regarding the measles, mumps, and rubella (MMR) vaccine, particularly the second dose...
- Communication and miscommunication of risk: understanding UK parents' attitudes to combined MMR vaccinationPaul Bellaby
Institute for Public Health Research and Policy, University of Salford, Greater Manchester M5 4QA
BMJ 327:725-8. 2003
- Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experienceAna Morice
Ministry of Health, San Jose, Costa Rica
J Infect Dis 187:S158-63. 2003..Targeting MR vaccination appropriately and using the opportunity to strengthen surveillance for rash illness has benefits beyond accelerated rubella control and CRS prevention, including strengthening of the measles eradication program...
- Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policyA J Vyse
PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
Epidemiol Rev 24:125-36. 2002
- Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy childrenHenry R Shinefield
Kaiser Permanente Vaccine Study Group, Oakland, CA 94612, USA
Pediatr Infect Dis J 21:555-61. 2002....
- Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st centuryA J Vyse
Health Protection Agency, Centre for Infections, Sero Epidemiology Unit, Immunisation Department, London, UK
Epidemiol Infect 134:1303-12. 2006..Investigations into the efficacy of two doses of a mumps containing vaccine should be a priority during the current epidemic...
- MMR uptake data are unlikely to be subject to manipulationMary Ramsay
BMJ 324:1394. 2002
- Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population studyBrent Taylor
Centre for Community Child Health, Royal Free and University College Medical School, University College London Royal Free Campus, London
BMJ 324:393-6. 2002..To investigate whether measles, mumps, and rubella (MMR) vaccination is associated with bowel problems and developmental regression in children with autism, looking for evidence of a "new variant" form of autism...
- Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunitySung Soo Kim
Department of Biomedical Sciences, National Institute of Health, 5 Nokbun dong, Eunpyung Gu, Seoul 122 701, South Korea
Vaccine 23:290-7. 2004..Furthermore, our results suggest continuous mumps outbreaks could occur because of the accumulation of susceptible individuals...
- Measles in the United Kingdom: can we eradicate it by 2010?Perviz Asaria
Infection and Immunology Delivery Unit, Guy s and St Thomas s NHS Foundation Trust, St Thomas s Hospital, London SE1 7EH
BMJ 333:890-5. 2006
- Measles control in NSW divisions of general practiceC Raina MacIntyre
National Centre for Immunisation Research, The University of Sydney and The Children s Hospital at Westmead
N S W Public Health Bull 14:13-7. 2003
- Sustained measles elimination in Australia and priorities for long term maintenanceHeather F Gidding
Centre for Infectious Diseases and Microbiology CIDM Public Health, ICPMR Building, 3rd Floor, Westmead Hospital, Westmead, and the University of Sydney, NSW, Australia
Vaccine 25:3574-80. 2007..This experience is likely to apply to developed countries that have achieved or are approaching measles elimination...
- The MMR vaccination and autism controversy in United Kingdom 1998-2005: inevitable community outrage or a failure of risk communication?David C Burgess
NHMRC Clinical Trials Centre, The University of Sydney, Sydney NSW 2006, Australia
Vaccine 24:3921-8. 2006..Coverage rates fell dramatically, and did not start to recover until 2004. Could this public reaction have been predicted?..
- Outbreak of mumps in a vaccinated child population: a question of vaccine failure?Corinne Vandermeulen
Department of Youth Health Care, Katholieke Universiteit Leuven, Kapucijnenvoer 35 1, 3000, Belgium
Vaccine 22:2713-6. 2004..The role of secondary vaccine failure is highlighted...
- 'Between the demands of truth and government': health practitioners, trust and immunisation workJulie Brownlie
Department of Applied Social Science, Stirling University, Colin Bell Building, UK
Soc Sci Med 62:433-43. 2006....
- Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohortsI Davidkin
National Public Health Institute, Helsinki, Finland
Vaccine 16:2052-7. 1998..It is important to follow how long the protection achieved by the present vaccine programme will last after elimination of indigenous measles...
- Effect of Pentavac and measles-mumps-rubella (MMR) vaccination on the intestineB Thjodleifsson
Department of Medicine, University Hospital, Hringbraut, Reykjavik, Iceland
Gut 51:816-7. 2002..In particular it has been suggested that the measles, mumps, and rubella (MMR) vaccination leads to brain damage manifesting as autism consequent to the development of an "enterocolitis" in the immediate post-vaccination period...
- Misleading media reporting? The MMR storyJustin Lewis
School of Journalism, Media and Cultural Studies, Cardiff University, UK
Nat Rev Immunol 3:913-8. 2003
- Misled and confused? Telling the public about MMR vaccine safety. Measles, mumps, and rubellaC J Clements
Department of Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
J Med Ethics 29:22-6. 2003....
- The vaccines for children program. Policies, satisfaction, and vaccine deliveryR K Zimmerman
Department of Family Medicine and Clinical Epidemiology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
Am J Prev Med 21:243-9. 2001..Characterize the Vaccines for Children (VFC) programs in Minnesota and Pennsylvania, assess providers' satisfaction with each state's program, and examine changes in doses administered in the public sector since implementation of the VFC...
- A mathematical model to measure the impact of the Measles Control Campaign on the potential for measles transmission in AustraliaC R Macintyre
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The New Children s Hospital, Westmead, NSW, Australia
Int J Infect Dis 6:277-82. 2002....
- A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed childrenChin Yun Lee
Department of Pediatrics, National Taiwan University Hospital, Taipei
Int J Infect Dis 6:202-9. 2002....
- Combination vaccine use and vaccination quality in a managed care populationLaura E Happe
Xcenda, Palm Harbor, FL 34685, USA
Am J Manag Care 13:506-12. 2007..To evaluate the impact of a pentavalent combination vaccine on childhood immunization coverage rates and timeliness within a managed care organization...
- [Issues related to rubella, measles and epidemic parotiditis in the Russian Federation]V V Zverev
Vopr Virusol 49:8-11. 2004....
- Varicella vaccines and measles, mumps, rubella, and varicella vaccineLucia Ferro Bricks
Departamento de Pediatria, Faculdade de Medicina da Universidade de São Paulo USP, Sao Paulo, SP, Brazil
J Pediatr (Rio J) 82:S101-8. 2006..To present an up-to-date review of studies investigating the efficacy, adverse events and vaccination regimens of the varicella vaccine and the new presentation combined with the vaccine for measles, mumps and rubella...
- Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological surveyC Amela
National Centrefor Epidemiology, Carlos III Institute of Public Health, Madrid, Spain
Eur J Epidemiol 18:71-9. 2003..A possible explanation for the higher susceptibility observed for mumps might lie in the Rubini strain's low efficacy...
- Risk factors for undervaccination against measles in a large sample of preschool children from rural BavariaA P Zucs
Postgraduate Program in Public Health, Ludwig Maximilian University School of Medicine, Marchioninistrasse 15, D 81377 Munich, Germany
Infection 32:127-33. 2004..Due to insufficient vaccination rates, measles outbreaks still pose a threat to public health in Germany. The purpose of this study was to identify risk factors for undervaccination against measles...
- Ethnicity as a correlate of the uptake of the first dose of mumps, measles and rubella vaccineRuth E Mixer
Postgraduate Education Centre, Charing Cross Hospital, Fulham Palace Road, Hammersmith, London, UK
J Epidemiol Community Health 61:797-801. 2007..An important association between ethnicity and uptake of MMR1 vaccine is observed. This has implications for efforts to improve the currently inadequate levels of MMR vaccination across the population as a whole...
- Epidemiology of measles, mumps and rubella in ItalyG Gabutti
Department of Health Sciences, Hygiene and Preventive Medicine Section, Faculty of Medicine, University of Genoa, Italy
Epidemiol Infect 129:543-50. 2002....
- [The knowledge about measles, mumps and rubella among parents in the county of Roskilde]Lars Folmer Hansen
Børneafdeling, Amtssygehuset Roskilde
Ugeskr Laeger 164:5748-52. 2002..The aim was to determine how much knowledge parents have of MMR diseases and the side effects of the vaccine, and what influence this has on acceptance of the vaccination programme...
- Global measles elimination efforts: the significance of measles elimination in the United StatesPeter M Strebel
Global Immunization Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 189:S251-7. 2004..This experience provides evidence that sustained interruption of transmission can be achieved in large geographic areas, suggesting the feasibility of global eradication of measles...
- [Vaccination against rubella, measles, chickenpox, and mumps in nursing students]Takayoshi Tashiro
Department of Nursing, Nagasaki University School of Health Sciences
Kansenshogaku Zasshi 78:398-403. 2004..6% in measles, 48.0% in chickenpox, 93.8% in mumps, respectively. Susceptible nursing students, as well as the medical stuff, should be vaccinated in order to prevent hospital infection of rubella, measles, chickenpox, and mumps...
- An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United StatesFangjun Zhou
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 189:S131-45. 2004..From both perspectives under even the most conservative assumptions, the national 2-dose MMR vaccination program is highly cost-beneficial and results in substantial cost savings...
- Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategyR Sultana
Department of Immunology, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders BIRDEM, Dhaka, Bangladesh
Scand J Immunol 64:684-9. 2006....
- Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix or MMR-IINina Knutsson
Primary Health and Medical Care, Child Health Centre, Munkebäckstorg, S 416 73 Göteborg, Sweden
Vaccine 24:5800-5. 2006..Mean VAS value was 2.3/5.2 for Priorix and MMR-II, respectively (p<0.001). Mean CHEOPS value was 1.9/6.1 for Priorix and MMR-II, respectively (p<0.001). The study shows that Priorix gives less immediate injection pain than MMR-II...
- [35-year measles, mumps, rubella vaccination assessment in France]P Reinert
Service de Pediatrie, Centre Hospitalier Intercommunal de Creteil, 40 rue de Verdun, 94010, Creteil, France
Arch Pediatr 10:948-54. 2003....
- [The triple virus vaccine: old viruses, new problems]Fernando de Ory
Enferm Infecc Microbiol Clin 25:227-9. 2007
- Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional studyJ Mossong
Laboratoire National de Santé, PO Box, 1102, L 1011 Luxembourg
Epidemiol Infect 132:11-8. 2004..Present vaccination coverage with MMR appears to be sufficient to prevent large local outbreaks of measles and rubella, but probably not mumps...
- Why do parents hesitate to vaccinate their children against measles, mumps and rubella?R Alfredsson
Department of Paediatrics, Institution of Women s and Children s health, Goteborg University, Goteborg, Sweden
Acta Paediatr 93:1232-7. 2004..Coverage among children 18 mo of age has been 99%, but the measles, mumps and rubella vaccination (MMR) has increasingly been questioned among parents...
- Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of ageStephen C Redd
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 189:S116-22. 2004..The response to mumps varied little by age of the child or birth year of the child's mother. These results support the recommended age for first vaccination with measles-mumps-rubella at 12-15 months...
- Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapyMatteo Zignol
Department of Pediatrics, Faculty of Medicine and Surgery, University of Padua, Padua, Italy
Cancer 101:635-41. 2004....
- Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infantsStephanie T Yerkovich
Telethon Institute for Child Health Research, and Centre for Child Health Research, Faculty of Medicine and Dentistry, The University of Western Australia, Perth, WA, Australia
Vaccine 25:1764-70. 2007..Parallel analyses of cytokine responses to phytohaemagglutinin and tetanus toxoid did not detect any "bystander" effects of the vaccines on systemic immunity...
- The contribution of single antigen measles, mumps and rubella vaccines to immunity to these infections in England and WalesPam Sonnenberg
Immunisation Department, Centre for Infections, Health Protection Agency, London, UK
Arch Dis Child 92:786-9. 2007..To obtain information on the use of single antigen measles, mumps and rubella vaccines to improve estimates of population immunity and help predict outbreaks...
- Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplantsV Spoulou
Department of Pediatrics, Athens University School of Medicine, Greece
Bone Marrow Transplant 33:1187-90. 2004..We conclude that a single dose of MMR given at 2 years after BMT induces suboptimal and short-lived immune responses to measles and mumps; a second dose should be recommended for paediatric BMT recipients...
- MMR debate fall-out continuesRachael Paterson
Lancet Infect Dis 4:653. 2004
- MMR vaccination: new thoughtVinayak Deshmukh
Indian Pediatr 43:555-6. 2006
- Feeling bad about immunising our childrenAbigail L Wroe
Department of Psychology, Institute of Psychiatry, Kings College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
Vaccine 23:1428-33. 2005....
- Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigensAnna Nilsson
Pediatric Cancer Research Unit, Astrid Lindgren Children Hospital, Stockholm, Sweden
Pediatrics 109:e91. 2002....
- A combination vaccine against measles, mumps, rubella and varicellaMarkus Knuf
Pediatric University Hospital, Johannes Gutenberg University, Mainz, Germany
Drugs Today (Barc) 44:279-92. 2008..For other countries considering introducing these vaccines, the advantages for children, parents and healthcare providers of protecting against four diseases in a single vaccine should be noted...
- Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of lifeVolker Schuster
Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany
Pediatr Infect Dis J 27:724-30. 2008..This study (104389/NCT00127023) was undertaken to assess the immunogenicity and safety of a new refrigerator-stable tetravalent MMRV vaccine after 1 dose and after 2 doses administered during the second year of life...
- Serosurvey of measles, mumps and rubella antibodies in Saudi childrenYagob Y Al-Mazrou
Department of Preventive Medicine, MOH, Riyadh, Kingdom of Saudi Arabia
Saudi Med J 26:1551-4. 2005..A serosurvey study to evaluate the proportion of children with antibodies against diseases targeted by the Expanded Program of Immunization in the Kingdom of Saudi Arabia...
- Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapyFrancesca Fioredda
Cancer 103:1758-9; author reply 1760. 2005
- Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapyHans Jürgen Laws
Cancer 103:1759; author reply 1760. 2005
- Live virus immunization after orthotopic liver transplantationSaba Khan
Department of Pediatrics, Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
Pediatr Transplant 10:78-82. 2006..Only minor adverse effects reported in the general population were observed. Live virus immunization with MMR and Varivax was safe and immunogenic in this selected population of liver transplant recipients...
- Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinatingDavid M Haas
Department of Obstetrics and Gynecology, Naval Hospital Camp Lejeune, Jacksonville, North Carolina 28547, USA
Obstet Gynecol 106:295-300. 2005..A secondary objective was to assess costs of vaccination and testing programs aimed at eliminating these viral susceptibilities to determine an optimal strategy...
- Postlicensure epidemiology of childhood vaccination: the Danish experienceAnders Hviid
Statens Serum Institut, Department of Epidemiology Research, Artillerivej 5, 2300 Copenhagen S, Denmark
Expert Rev Vaccines 5:641-9. 2006....
- Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old childrenCornelia Feiterna-Sperling
Charite University Medicine Berlin, Berlin, Germany
Pediatr Infect Dis J 24:1083-8. 2005..This study compared the immunogenicity and safety of MMR Berna, which is produced entirely in human diploid cells, with those of the licensed vaccine M-M-RVax (Merck & Co.)...
- Humoral and cellular immune response after measles vaccination in TaiwanChou Lang Huang
Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
J Microbiol Immunol Infect 38:169-75. 2005....
- The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibodyJay M Lieberman
Miller Children s Hospital, UCLA Center for Vaccine Research, Long Beach, CA 90806, USA
Pediatr Infect Dis J 25:615-22. 2006..An additional objective was to evaluate the persistence of antibodies 1 year postvaccination...
- A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicellaJose Ramet
Department of Pediatrics, Universitair Ziekenhuis Antwerpen, Antwerp Belgium
Int J Infect Dis 11:S49-55. 2007..Varicella is often considered to be a benign disease of childhood. In fact, varicella is associated with serious complications and mortality even among healthy individuals...
- [Post-transplantation vaccination of bone-marrow transplant recipients]Carmen Adell
Centro de Vacunación de Adultos Servicio de Medicina Preventiva UASP IDIBAPS Hospital Clínic Barcelona España
Med Clin (Barc) 119:405-9. 2002..The objective of this study was to determine the susceptibility to vaccine-preventable diseases in people subject to BMT and the serologic response after vaccination...
- Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003Armenak Asatryan
Science Applications International Corporation and Emory University School of Medicine, Atlanta, GA, USA
Vaccine 26:1166-72. 2008..Thus, HL following MMCV has been reported in the literature and to the VAERS. Further studies are needed to better understand if there is a causal relationship between MMCV and HL...
- Pediatric sentinel surveillance of vaccine-preventable diseases in ItalyMarta Luisa Ciofi degli Atti
Laboratorio di Epidemiologia e Biostatistica, Istituto Superiore di Sanita, Rome, Italy
Pediatr Infect Dis J 21:763-8. 2002..In January, 2000, a pediatric sentinel network was launched, with the aim of monitoring in a timely and accurate way the geographic and temporal trends of vaccine-preventable diseases...
- Reliability of medical students' vaccination histories for immunisable diseasesSabine Wicker
Occupational Health Service, Hospital of the Johann Wolfgang Goethe University of Frankfurt, Theodor Stern Kai 7, 60590 Frankfurt, Germany
BMC Public Health 8:121. 2008..Medical students come into contact with infectious diseases early on their career. Immunity against vaccine-preventable diseases is therefore vital for both medical students and the patients with whom they come into contact...
- [Seroprevalence of measles antibody and its attributable factors in elementary students of routine 2-dose schedule era with vaccination record]Geun Ryang Bae
Department of Preventive Medicine, College of Medicine, Dongguk University
J Prev Med Public Health 38:431-6. 2005..We investigated the seroprevalence of the measles antibody and its attributable factors for the students who underwent routine 2-dose Schedule Era...
- Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United StatesVitali Pool
Vaccine Safety and Development Activity, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Pediatrics 110:e71. 2002....
- Antibody responses of healthy infants to concurrent administration of a bivalent haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccinesD J West
BioDrugs 15:413-8. 2001....
- Impact of a decline in Colorado Medicaid managed care enrollment on access and quality of preventive primary care servicesStephen Berman
Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado, USA
Pediatrics 116:1474-9. 2005..5% to 25.3%. This shift of children from HMO managed care to the UFFS program provided a natural experiment to assess the impact of not having an assigned PCP on pediatric primary care services...
- The association between having a medical home and vaccination coverage among children eligible for the vaccines for children programPhilip J Smith
Centers for Disease Control and Prevention, National Immunization Program, MS E 32, 1600 Clifton Rd, NE, Atlanta, GA 30333, USA
Pediatrics 116:130-9. 2005..A desired consequence of the program is to promote comprehensive continuous medical care within a medical home for these children...
- Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R II, VARIVAX and TETRAMUNE in healthy children vs. concomitant injections of M-M-R II and TETRAMUNE followed six weeks later by VARIVAXH R Shinefield
Kaiser Permanente Vaccine Study Center, Oakland, CA 94115, USA
Pediatr Infect Dis J 17:980-5. 1998..Local and systemic adverse reactions were recorded. Exposure and cases of varicella were documented through a 1-year follow-up period...
- Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccineTerry Nolan
The University of Melbourne, Department of Paediatrics, and Murdoch Children s Research Institute at the Royal Children s Hospital, Melbourne, Australia
Vaccine 21:281-9. 2002..This tetravalent MMRV candidate vaccine showed promising results, although further examination of the possible increase in minor fever and decreased varicella immunogenicity should be assessed in future studies...
- Delays in receipt of immunizations in low-birth-weight children: a nationally representative sampleD L Langkamp
Children s Hospital, Room H310, 700 Children s Dr, Columbus, OH 43205, USA
Arch Pediatr Adolesc Med 155:167-72. 2001..However, a recent study of VLBW children in 3 health maintenance organizations found no significant delays in immunizations...
- Population-based study of the adequacy of well-child care services: a rural county's report cardA M Gadomski
Research Institute, Mary Imogene Bassett Hospital, Cooperstown, NY, USA
Arch Pediatr Adolesc Med 152:745-8. 1998..To determine the adequacy of well-child care services using a population-based study...
- Assessing immunization performance of private practitioners in Maine: impact of the assessment, feedback, incentives, and exchange strategyM S Massoudi
Centers for Disease Control and Prevention, National Immunization Program, Atlanta, Georgia, USA
Pediatrics 103:1218-23. 1999..The Maine Immunization Program, and the Maine Chapter of the American Academy of Pediatrics collaborated on the implementation and evaluation of this strategy among private providers...
- Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to CanadaSusan Hahne
Centre for Infectious Disease Control, National Institute for Public Health and the Environment RIVM, The Netherlands
Pediatr Infect Dis J 28:795-800. 2009..In The Netherlands and Canada the measles, mumps, rubella vaccine coverage is high. In 2004 a rubella outbreak started in the Netherlands in a population subgroup with low coverage, with subsequent spread to Canada...
- Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubellaKeri Wellington
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 63:2107-26. 2003..Furthermore, GSK-MMR causes fewer injection-site adverse events than Merck-MMR. As such, GSK-MMR is an attractive alternative for immunisation against measles, mumps and rubella...
- Associations between childhood vaccination coverage, insurance type, and breaks in health insurance coveragePhilip J Smith
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Pediatrics 117:1972-8. 2006..This study explored how vaccination coverage is associated with not being insured and with insurance type among children who are insured and to show how these associations are modified by race/ethnicity...
- Sero-response to measles-mumps-rubella vaccine campaign in Saudi ArabiaYagob Y Al-Mazrou
Department of Preventive Medicine, Ministry of Health, Qassim, Kingdom of Saudi Arabia
Saudi Med J 23:680-3. 2002..To evaluate the measles-mumps-rubella vaccine campaign targeting primary school children in the Kingdom of Saudi Arabia during the months of January and February 2000...
- Vaccinations and risk of central nervous system demyelinating diseases in adultsFrank Destefano
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Arch Neurol 60:504-9. 2003..Several case reports of the onset or exacerbation of multiple sclerosis or other demyelinating conditions shortly after vaccination have suggested that vaccines may increase the risk of demyelinating diseases...
- Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemiaTugba Erener Ercan
Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey
J Pediatr Hematol Oncol 27:273-7. 2005..Children with ALL can receive the appropriate vaccines during and after maintenance treatment...
- Measles vaccination and inflammatory bowel disease: controversy laid to rest?R L Davis
Department of Paediatrics, University of Washington School of Medicine, Seattle, Washington 98103, USA
Drug Saf 24:939-46. 2001....
- CHIP shots: association between the State Children's Health Insurance Programs and immunization ratesTed Joyce
Department of Economics, Baruch College, City University of New York, New York, USA
Pediatrics 115:e526-34. 2005..The objective of this study was to use data from the National Immunization Survey from 1995 to 2002 to analyze changes in immunization coverage rates among poor, near-poor, and nonpoor children before and after implementation of SCHIP...
- Measles outbreak in Japan: Why now?Kanako Masuno
Biosci Trends 1:3. 2007
- HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccineInna G Ovsyannikova
Mayo Vaccine Research Group, Mayo Clinic and Foundation, Guggenheim 611C, 200 1st Street SW, Rochester, MN 55905, USA
Immunogenetics 56:798-807. 2005..These data suggest that IFN-gamma and IL-4 cytokine responses to measles may be genetically restricted in part by HLA class II genes, which in turn can restrict the cellular immune response to measles vaccine...
- Effectiveness of a vaccination program against mumps in UkraineY Hrynash
Department of Pediatric Infectious Diseases, Lviv National Medical University, 69 Pekarska St, 79010, Lviv, Ukraine
Eur J Clin Microbiol Infect Dis 27:1171-6. 2008..The use of vaccine with a derivate of the Jeryl Lynn strain has resulted in a dramatic drop in mumps cases since 2002...
- Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of ageM Ceyhan
Division of Pediatric Infectious Diseases, Hacettepe University School of Medicine, 06100, Ankara, Turkey
Vaccine 19:4473-8. 2001..All children had been followed for occurrence of measles infection for 60 months. Two vaccination schedules were compared for immunogenicity and protection rates...
- Childhood vaccination and nontargeted infectious disease hospitalizationAnders Hviid
Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
JAMA 294:699-705. 2005....
- Adolescent vaccination: coverage achieved by ages 13-15 years, and vaccinations received as recommended during ages 11-12 years, National Health Interview Survey 1997-2003Mary Mason McCauley
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
J Adolesc Health 43:540-7. 2008..To present progress toward Healthy People 2010 vaccination objectives for adolescents aged 13-15 years, and to determine how much catch-up and routine vaccination was administered at the recommended ages of 11-12 years...
- Vaccination status of children in the Women, Infants, and Children (WIC) Program: are we doing enough to improve coverage?A M Shefer
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Am J Prev Med 20:47-54. 2001..Vaccination-promoting strategies in the Supplemental Nutrition Program for Women, Infants, and Children (WIC) have been shown to produce dramatic improvements in coverage and other health outcomes...
- Short Tandem Repeat Polymorphisms in CytomegalovirusJames Bale; Fiscal Year: 2003..Characterizing HCM' strains by STR analysis will facilitate future studies of HCMV evolution and will provide a novel means t to fingerprint HCMV strains. ..
- Trainee-Focusted Training for Research IntegritySteven Jacobsen; Fiscal Year: 2003..6. Identify high frequency perceptions or frames of reference, which are substantially at odds with accepted research norms and begin designing better interventions to alter them. ..
- ENHANCING MUCOSAL IMMUNE RESPONSES BY MICROENCAPSULATIONPaul Offit; Fiscal Year: 2005..The availability of microencapsulated virus provides a unique opportunity to understand the relationship between APC and protective mucosal immune responses. ..
- Study of risk factors of tick-borne encephalitis in PolandPawel Stefanoff; Fiscal Year: 2009....
- DETERMINING/UNDERSTANDING BARRIERS TO ADULT IMMUNIZATIONRichard Zimmerman; Fiscal Year: 2001..This project will furnish relevant, up-to-date to enhance policy planning, practice management and medical education. ..
- Using MEPS Data to Inform Public-Plan ConsumerismMatthew Davis; Fiscal Year: 2007..Findings will have immediate relevance for implementation of the HOA projects and other consumerism efforts. [unreadable] [unreadable] [unreadable]..
- Parental Involvement Laws and Reproductive OutcomesTheodore Joyce; Fiscal Year: 2006..Teens who do not involve their parents may take longer to obtain an abortion either out of state or through a judicial bypass. Thus, we expect PI laws to increase the rate of second trimester abortions among minors. ..
- Parent Initiated Prevention ProgramDimitri Christakis; Fiscal Year: 2005..3) To improve parental perceptions of the quality of care provided.H3: Compared to controls, PIPP parents will report higher scores on selected Consumer Assessment of Health Plans (CAHPS) items. ..
- UNSTUDIED INFANTS: LOW RISK BABIES IN A HIGH RISK PLACEMarie McCormick; Fiscal Year: 2002..Results will identify sites with better outcomes and the practices associated with them. These outcomes represent achievable goals well within the scope of current technology. ..
- Internet Based Patient-Centered Asthma Management SystemDimitri Christakis; Fiscal Year: 2009..Children in AsthmaNet families will be more likely to report using written care plans. Aim 4: to decrease the number of symptom days for children with asthma H4. Children in AsthmaNet families will experience fewer symptom days. ..
- VZV Receptors and Infective MechanismsAnne Gershon; Fiscal Year: 2007..It may also make it possible to develop a safer and more efficacious vaccine. ..
- MOLECULAR APPROACHES TO CHILDHOOD PSYCHIATRIC DISORDERSMatthew State; Fiscal Year: 2006..abstract_text> ..
- The Role of SLITRK1 in Tourette and Related DisordersMatthew W State; Fiscal Year: 2010..The purpose of this study is to better understand .what causes TD by identifying additional abnormalities in the SLITRK1 gene and by investigating the impact of these unusual genetic changes on the developing brain. ..
- PEDIATRICS AIDS CLINICAL TRIALS GROUPAnne Gershon; Fiscal Year: 2006..We have competent, outstanding staff whose aim is not only to provide compassionate medical care to HIV-infected patients but also to perform meaningful and useful research on prevention and treatment of HIV infection. ..
- Molecular Cytogenetics and Tourette DisorderMatthew State; Fiscal Year: 2006..abstract_text> ..